Atlas FDA

ELECSYS ANTI-HBC-IGM ON MODULAR ANALYTICS E170

FDA premarket approval P110025/S004 · decided 2012-02-27

Approval details

PMA number
P110025
Supplement
S004
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ELECSYS ANTI-HBC-IGM ON MODULAR ANALYTICS E170
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Roche Diagnostics Corp.
Date received
2012-02-02
Decision date
2012-02-27
Days to decision
25 days
Decision code
OK30
Product code
LOM
Advisory committee
Immunology
Expedited review
No
Location
Indianapolis, IN
Statement
CHANGE TO THE IN- PROCESS PARTICLE CONCENTRATION DETERMINATION METHOD FOR THE INTERMEDIATE STORAGE FORM (ISF) BULK COMPONENT COMMON TO ALL DEVICES.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SUPER SANI-CLOTH/ ACCU-CHEK INFORM II SYSTEM (K130138)Roche Diagnostics Corp.2013-03-15
ELECSYS CA 19-9 CALCHECK 5 (K101365)Roche Diagnostics Corp.2010-10-05
COBAS 8000 MODULAR SERIES ANALYZER (K100853)Roche Diagnostics Corp.2010-09-09
ACCU-CHEK ULTRFLEX INFUSION SET (K101196)Roche Diagnostics Corp.2010-08-27
AMPHETAMINES II ASSAY (K093664)Roche Diagnostics Corp.2010-07-28
ELECSYS INSULIN CALCHECK 5 (K101075)Roche Diagnostics Corp.2010-06-11
ELECSYS TESTOSTERONE II IMMUNOASSAY (K093421)Roche Diagnostics Corp.2010-04-23
ELECSYS TROPONIN T CALCHECK 5 (K092848)Roche Diagnostics Corp.2010-03-19